교수소개

기초교실 교수활동 - 실천

임상교실

임상교실

안규정 교수

영문이름 -
Ahn Kyu-Jeung
교실 -
내분비내과학교실
전공 -
M.D., Ph.D. Endocrinology and Metabolism
연락처 -
02-440-6125
연구실 -
신관 405호
E-mail -
ahnkj@khu.ac.kr
홈페이지 -
https://khu.elsevierpure.com/en/persons/kyu-jeung-ahn
비고 -
강동 경희대학교병원
- 당뇨병, 갑상선, 비만, 뇌하수체, 부신
- 경희대학교 의과대학 학사, 석사, 박사
- 삼성의료원 내분비대사 내과 전임의 수련
- 관동대학교 의과대학 조교수
- 을지의과대학교 의학과 부교수
- 캐나다 알버타대학교 췌도이식 프로그램 연수
- 강동경희대학교병원 내분비대사센터(내분비내과) 교수
- 2011 ~ 2018, 강동경희대의대병원 내분비내과 과장
- 2011 ~ 2018, 강동경희대의대병원 내분비대사센터장
- 2012 ~ 2016, 강동경희대학교병원 임상의학연구소 중앙실험실장
- 現 강동경희대학교병원 내과부장
- 대한내과학회 평생회원
- 대한당뇨병학회 평생회원
- 대한내분비학회 평생회원
- 미국내분비학회 정회원
- 미국당뇨병학회 회원
1 Rhee, S. Y., Chon, S., Ahn, K. J., Woo, J. T. & Korean Diabetes Prevention Study, I. Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study. Diabetes Metab J 43, 49-58, doi:10.4093/dmj.2018.0033 (2019).
2 Mohan, V. et al. Lilly Insulin Glargine Versus Lantus((R)) in Type 2 Diabetes Mellitus Patients: India and East Asia Subpopulation Analyses of the ELEMENT 5 Study. Clin Drug Investig, doi:10.1007/s40261-019-00798-1 (2019).
3 Kim, H. J. et al. Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: A 12-Week Interim Report. Diabetes Ther 10, 1271-1282, doi:10.1007/s13300-019-0628-0 (2019).
4 Jun, J. E. et al. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study. Atherosclerosis 283, 28-34, doi:10.1016/j.atherosclerosis.2019.01.030 (2019).
5 Hwang, Y. C., Jun, J. E., Jeong, I. K., Ahn, K. J. & Chung, H. Y. Comparison of the Efficacy of Rosuvastatin Monotherapy 20 mg with Rosuvastatin 5 mg and Ezetimibe 10 mg Combination Therapy on Lipid Parameters in Patients with Type 2 Diabetes Mellitus. Diabetes Metab J, doi:10.4093/dmj.2018.0124 (2019).
6 Hirose, T., Chen, C. C., Ahn, K. J. & Kiljanski, J. Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review. Diabetes Ther 10, 805-833, doi:10.1007/s13300-019-0613-7 (2019).
7 Yoo, J. et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces hepatic steatosis and endoplasmic reticulum stress by inducing nuclear factor erythroid-derived 2-related factor 2 nuclear translocation. Toxicol Appl Pharmacol 360, 18-29, doi:10.1016/j.taap.2018.09.032 (2018).
8 Kim, J. D. et al. Comparison of Adherence to Glimepiride/Metformin Sustained Release Once-daily Versus Glimepiride/Metformin Immediate Release BID Fixed-combination Therapy Using the Medication Event Monitoring System in Patients With Type 2 Diabetes. Clin Ther 40, 752-761 e752, doi:10.1016/j.clinthera.2018.04.002 (2018).
9 Kim, H. J. et al. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort. Medicine (Baltimore) 97, e0036, doi:10.1097/MD.0000000000010036 (2018).
10 Jeon, J. Y. et al. Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program. J Diabetes Investig 9, 1144-1152, doi:10.1111/jdi.12801 (2018).
11 Hwang, Y. C. et al. Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. Korean J Intern Med 33, 347-355, doi:10.3904/kjim.2015.208 (2018).
12 Hwang, Y. C., Cho, I. J., Jeong, I. K., Ahn, K. J. & Chung, H. Y. Factors associated with regression from prediabetes to normal glucose tolerance in a Korean general population: A community-based 10-year prospective cohort study. Diabet Med, doi:10.1111/dme.13789 (2018).
13 Chon, S. et al. Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial. Diabetes Obes Metab 20, 1121-1130, doi:10.1111/dom.13196 (2018).
14 Park, S. Y. et al. Effects of foot complications in patients with Type 2 diabetes mellitus on public healthcare: An analysis based on the Korea National Diabetes Program Cohort. J Diabetes Complications 31, 375-380, doi:10.1016/j.jdiacomp.2016.06.024 (2017).
15 Park, J. et al. Efficacy and safety of evogliptin monotherapy in patients with type 2 diabetes and moderately elevated glycated haemoglobin levels after diet and exercise. Diabetes Obes Metab 19, 1681-1687, doi:10.1111/dom.12987 (2017).
16 Min, K. W. et al. Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial. Diabetes Metab J 41, 135-145, doi:10.4093/dmj.2017.41.2.135 (2017).
17 Hwang, Y. C. et al. Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. Korean J Intern Med, doi:10.3904/kjim.2015.208 (2017).
18 Hwang, Y. C., Cho, I. J., Jeong, I. K., Ahn, K. J. & Chung, H. Y. Differential association between sarcopenia and metabolic phenotype in Korean young and older adults with and without obesity. Obesity (Silver Spring) 25, 244-251, doi:10.1002/oby.21694 (2017).
19 Chon, S. et al. Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial. Diabetes Obes Metab, doi:10.1111/dom.13196 (2017).
20 Ahn, C. H. et al. Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study (TROICA study). Diabetes Obes Metab 19, 635-643, doi:10.1111/dom.12866 (2017).

Quick Link

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

대학소개
교수소개
입학
교육
학생생활
커뮤니티
ENG
닫기